Table 1 Previously functionally validated SNPs affecting miRNA binding evaluated by TargetScan and miRanda.

From: Allele-specific miRNA-binding analysis identifies candidate target genes for breast cancer risk

SNP

Locus

Gene

Transcripta

miRNAb

Allelesc

Ref. allele

Alt. allele

Associated disease

      

Context ++d

MFEe

Context ++d

MFEe

 

rs4245739[f21

1q32

MDM4

ENST00000367182.3

hsa-miR-191-5p

A/C

−0.309

Ovarian cancer

rs793013

1q42.3

TOMM20

ENST00000366607.4

hsa-miR-4273-5p

A/G

−0.151

Colorectal cancer

rs3559256722

3q28

TP63

ENST00000264731.3

hsa-miR-140-5p

C/T

−0.234

Bladder cancer

rs107173816

4q32.3

PALLD

ENST00000261509.6

hsa-miR-96-5p

G/C

−0.12

Breast cancer

    

hsa-miR-182-5p

 

−0.298

 
   

ENST00000335742.7

hsa-miR-96-5p

 

−0.126

 
    

hsa-miR-182-5p

 

−0.317

 

rs1272020823

8p22

FGF20

ENST00000180166.5

hsa-miR-433-3p

G/A

−0.201

Parkinson’s disease

rs422524

11q23.3

APOC3

ENST00000227667.3

hsa-miR-4271

G/T

−16.69

−0.172

−21.07

Coronary heart disease

rs11540855f20

19p13.11

ABDH8

ENST00000247706.3

hsa-miR-4707-3p

A/G

−23.93

−0.225

−25.95

  1. aTranscript ID of the 3′-UTR sequence used in TargetScan’s miRNA-binding predictions
  2. bmiRNA ID from miRbase v21
  3. cReference allele/alternative allele(s)
  4. dObtained from TargetScan v7.1
  5. eMinimum free energy (MFE, from miRanda v3.3a) for the corresponding prediction obtained in TargetScan
  6. fSNP associated in GWAS with breast cancer risk, all others are proxies GWAS-significant variants in the corresponding loci